
Paul Heidenreich MD
Adult Congenital Heart Disease, Echocardiography, Cardiothoracic Imaging
Professor, Medicine - Cardiovascular Medicine, Stanford University Medical Center
Join to view full profile
300 Pasteur DrStanford, CA 94305
Phone+1 650-723-4000
Fax+1 650-496-2584
Dr. Heidenreich is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Fellowship, Cardiovascular Disease, 1992 - 1995
University of California (San Francisco)Residency, Internal Medicine, 1990 - 1992
UCLA David Geffen School of Medicine/UCLA Medical CenterInternship, Internal Medicine, 1989 - 1990
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1988
Certifications & Licensure
CA State Medical License 1990 - 2027
American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Clinical Trials
Publications & Presentations
PubMed
- Inpatient Initiation of Target-Dose ACE Inhibitors and Lower Risk of Death or Kidney Failure in Veterans With HFrEF: Results From the National DCVA-HF Registry.Cherinne Arundel, Venkatesh K Raman, Sijian Zhang, Helen M Sheriff, Jessica J Logan
Journal of Cardiac Failure. 2026-08-21 - Target Versus Below-Target Dose ACE Inhibitors in U.S. Veterans with HFpEF: Differential Outcomes by CKD Status.Frederick Lu, Amiya A Ahmed, Sijian Zhang, Venkatesh K Raman, Samir S Patel
European Journal of Heart Failure. 2026-07-30 - Delayed Diagnosis of Transthyretin Cardiac Amyloidosis Is Associated With Heart Failure Hospitalizations and Mortality.Gabriela Spencer-Bonilla, Jun Fan, Anubodh Sunny Varshney, Paul Cheng, Natasha Din
JACC. Advances. 2026-07-22
Journal Articles
- Applicability of US Food and Drug Administration Labeling for Dapagliflozin to Patients with Heart Failure with Reduced Ejection Fraction in US Clinical PracticeMuthiah Vaduganathan, Javed Butler, Paul A Heidenreich, Michelle M Kittleson, Anjali Tiku Owens, Pamela N Peterson, Clyde W Yancy, Gregg C Fonarow, JAMA Cardiology
- Quality of Care and Outcomes Among Medicare Advantage vs Fee-for-Service Medicare Patients Hospitalized with Heart FailureRishi K Wadhera, Paul A Heidenreich, Clyde W Yancy, Deepak L Bhatt, JAMA Cardiology
- Trends in Readmission and Mortality Rates Following Heart Failure Hospitalization in the Veterans Affairs Health Care System from 2007 to 2017Shun Kohsaka, Alexander T Sandhu, Paul A Heidenreich, JAMA Cardiology
Authored Content
- Trends in Readmission and Mortality Rates Following Heart Failure Hospitalization in the Veterans Affairs Health Care System from 2007 to 2017June 2020
- Trends in Readmission and Mortality Rates Following Heart Failure Hospitalization in the Veterans Affairs Health Care System from 2007 to 2017June 2020
- US Department of Justice Investigations of Implantable Cardioverter-Defibrillators and Quality Improvement in Health CareJuly 2018
Press Mentions
Guidelines Issued for Vaccination as Part of Cardiovascular CareOctober 2nd, 2025
Focus on Prevention | ACC Streamlines Immunization Recommendations for CVDOctober 1st, 2025
Why All Heart Patients Should Be Vaccinated Against the Flu, COVID-19, RSVSeptember 12th, 2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:








